Abstract
Objective
Atosiban has been shown to be an effective tocolytic agent with a low rate of side effects during 24 to 33 weeks of gestation. Atosiban acts through selective, competitive inhibition of both oxytocin and vasopressin, so that there are reasons to assume that a tocolytic effect can also be achieved earlier in the pregnancy.
Study design
In this prospective, randomized pilot study, 20 women in the 18th through 24th week of gestation who presented at our hospital with preterm labor were treated with atosiban. In the control group 20 women received saline infusions. All patients received antibiotic therapy. A cervical cerclage was performed when indicated as was correction of the vaginal pH.
Results
The tocolytic effect began after 3–10 min (median: 6.5 min). Treatment time until the complete absence of contractions was 3–12 h (median: 7.5 h). Pregnancies were prolonged between 11.1 and 21.7 weeks (median: 15.6 weeks) in the atosiban group vs. 10.5–19.1 weeks in the control group. If well tolerated, atosiban was continued. There were no significant alterations in the routine laboratory parameters, circulation parameters, and fluid balance.
Conclusion
In summary, atosiban showed itself to be effective for tocolytic treatment for premature labor, even during 18 and 24 weeks of pregnancy, while exhibiting its known, favorable profile of side effects.
Similar content being viewed by others
References
Akerlund M (2002) Involvement of oxytocin and vasopressin in the pathophysiology of preterm labor and primary dysmenorrhoea. Prog Brain Res 139:359–365
Akerlund M, Stromberg P, Hauksson A, Andersen LF, Lyndrup J, Trojnar J et al (1987) Inhibition of uterine contractions of premature labour with an oxytocin analogue. Results from a pilot study. Br J Obstet Gynaecol 94:1040–1044
Akerlund M, Melin P, Maggi M (1995) Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea. Adv Exp Med Biol 395:595–600
Althuisius SM, Dekker GA, Hummel P, Bekedam DJ, van Geijn HP (2001) Final results of the cervical incompetence prevention randomized cerclage trial (CIPRACT): therapeutic cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol 185:1106–1112
Andersen LF, Lyndrup J, Akerlund M, Melin P (1989) Oxytocin receptor blockade: a new principle in the treatment of preterm labor? Am J Perinatol 6:196–199
Bossmar T (1998) Treatment of preterm labor with the oxytocin and vasopressin antagonist atosiban. J Perinat Med 26:458–465
Bossmar T, Akerlund M, Szamatowicz J, Laudanski T, Fantoni G, Maggi M (1998) Receptor-mediated uterine effects of vasopressin and oxytocin in nonpregnant women. Br J Obstet Gynaecol 102:907–912
Fuchs AR, Fuchs F, Husslein P, Soloff MS, Fernström MJ (1982) Oxytocin and human parturition: a dual role for oxytocin in the initiation of labor. Science 251:1396–1398
Fuchs AR, Fuchs F, Husslein P, Soloff MS (1984) Oxytocin receptors in the human uterus during pregnancy and parturition. Am J Obstet Gynecol 150:734–741
Fuchs AR, Fuchs F, Soloff MS (1985) Oxytocin receptors in nonpregnant human uterus. J Clin Endocrinol Metab 60:37–41
Fuchs AR, Behrens O, Maschek H, Kupsch E, Einspanier A (1998) Oxytocin and vasopressin receptors in human and uterine myomas during menstrual cycle and early pregnancy. Hum Reprod Update Sep–Oct 4:594–604
Gimpl G, Fahrenholz F (2001) The oxytocin receptor system: structure, function, and regulation. Physiol Rev 81:629–683
Goldenberg RL (2002) The management of preterm labor. Obstet Gynecol 100:1020–1037
Goldenberg RL, Hauth JC, Andrews WW (2000) Intrauterine infection and preterm birth. N Engl J Med 342:1500–1507
Goodwin TM, Paul R, Silver H, Spellacy W, Parsons M, Chez R et al (1994) The effect of oxytocin receptor antagonist atosiban on preterm uterine activity in the human. Am J Obstet Gynecol 170:474
Hack M, Fanaroff AA (1990) Outcomes of children of extremely low birthweight and gestational age in the 1990s. Early Hum Dev 53:193–218
Harger JM (1983) Cervical cerclage: patient selection, morbidity, and success rates. Clin Perinatol 10:321–341
Kenyon SL, Taylor DJ, Tarnow-Mordi W (2001) Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. Lancet 357:989–994
Kimura T, Azuma C, Saji F et al (1992) Estimation by an electrophysiological method of the expression of oxytocin receptor mRNA in human myometrium during pregnancy. J Steroid Biochem Mol Biol 42:253–258
Kimura T, Takemura M, Nomura S et al (1996) Expression of oxytocin receptor in human pregnant myometrium. Endocrinology 137:780–785
King J, Flenady V (2000) Antibiotics for preterm labour with intact membranes. Cochrane Database Syst Rev 2:CD000246
Moutquin JM, Sherman D, Cohen H, Mohide PT, Hochner-Celnikier D, Fejgin M et al (2000) Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am J Obstet Gynecol 182:1191–1199
Novy MJ, Gupta A, Wothe DD, Gupta S, Kennedy KA, Gravett MG (2001) Cervical cerclage in the second trimester of pregnancy: a historical cohort study. Am J Obstet Gynecol 184:1447–1456
Owen J, Iams JD, Hauth JC (2003) Vaginal sonography and cervical incompetence. Am J Obstet Gynecol 188:586–596
Quinones-Jenab V, Jenab S, Ogawa S, Adan RA, Burbach JP, Pfaff DW (1997) Effects of estrogen on oxytocin receptor messenger ribonucleic acid expression in the uterus, pituitary, and forebrain of the female rat. Neuroendocrinology 65:9–17
Rezapour M, Backstrom T, Ulmsten U (1996) Myometrial steroid concentration and oxytocin receptor density in parturient women at term. Steroids 61:338–344
Richter ON, Tschubel K, Schmolling J, Kupka M, Ulrich U, Wardelmann E (2003) Immunohistochemical reactivity of myometrial oxytocin receptor in extracorporeal perfused non-pregnant human uteri. Arch Gynecol Obstet 269:16–24
Robinson RS, Mann GE, Lamming GE, Wathes DC (1999) The effect of pregnancy on the expression of uterine oxytocin, oestrogen and progesterone receptors during early pregnancy in the cow. J Endocrinol 160:21–33
Robinson RS, Mann GE, Lamming GE, Wathes DC (2001) Expression of oxytocin, oestrogen and progesterone receptors in uterine biopsy samples throughout the oestrous cycle and early pregnancy in cows. Reproduction 122:965–979
Romero R, Mazor M, Munoz H, Gomez R, Galasso M, Sherer DM (1994) The preterm labor syndrome. Ann NY Acad Sci 734:414–429
Romero R, Sibai BM, Sanchez-Ramos L, Valenzuela GJ, Veille JC, Tabor B et al (2000) An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 182:1173–1183
Rust OA, Atlas RO, Reed J, van Gaalen J, Balducci J (2001) Revisiting the short cervix detected by transvaginal ultrasound in the second trimester: why cerclage may not help. Am J Obstet Gynecol 185:1098–1105
Starbuck GR, Stout TA, Lamming GE, Allen WR, Flint AP (1998) Endometrial oxytocin receptor and uterine prostaglandin secretion in mares during the oestrous cycle and early pregnancy. J Reprod Fertil 113:173–179
Thomsen AC, Morup L, Hansen KB (1987) Antibiotic elimination of group B streptococci in urine in prevenetion of preterm labour. Lancet 1:591–593
Thornton S, Vatish M, Slater D (2001) Oxytocin antagonists: clinical and scientific considerations. Exp Physiol 86:297–302
Thorp JM, Hartmann KE, Berkman ND, Carey TS, Lohr KN, Gavin NI et al (2002) Antibiotic therapy for the treatment of preterm labor: a review of the evidence. Am J Obstet Gynecol 186:587–592
Valentin L, Slakevicius P, Kindahl H, Broeders A, Marsal K, Melin P (2000) Effects of a vasopressin antagonist in women with dysmenorrhoea. Gynecol Obstet Invest 50:170–177
Valenzuela GJ, Sanchez-Ramos L, Romero R, Silver HM, Koltun WD, Millar L et al (2000) Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group. Am J Obstet Gynecol 182:1184–1190
Watts DH, Krohn MA, Hillier SL, Eschenbach DA (1994) Randomized trial of antibiotics in addition to tocolytic therapy to treat preterm labor. Infect Dis Obstet Gynecol 1:220–227
Worldwide Atosiban Versus Beta-agonists Study Group (2001) Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labor. Br J Obstet Gynaecol 108:133–142
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Richter, O.N., Dorn, C., van de Vondel, P. et al. Tocolysis with atosiban: experience in the management of premature labor before 24 weeks of pregnancy. Arch Gynecol Obstet 272, 26–30 (2005). https://doi.org/10.1007/s00404-004-0652-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-004-0652-8